MD
University of Calgary, United States
Holly Lee, MD, is a hematologist and PhD candidate at Arnie Charbonneau Cancer Institute in Canada. She is a part of the Clinician Investigator Program at University of Calgary and is supervised by Dr Nizar Bahlis. Her research focuses on investigating mechanisms of resistance to immunotherapies in multiple myeloma.
Disclosure information not submitted.
OA – 10: Impaired membrane trafficking of GPRC5D mediates resistance to anti-GPRC5D TCE
Friday, September 27, 2024
5:54 PM - 6:06 PM East Coast USA Time